Aura Biosciences, Inc. 4

Teresa Marie Bitetti received 15,000 RSUs and a 30,000-share stock option (exercise price $6.21) in Aura Biosciences, Inc. as equity awards on June 11, 2026.

On June 11, 2026, Aura Biosciences, Inc. insider Teresa Marie Bitetti received an equity compensation package consisting of 15,000 shares of common stock pursuant to a restricted stock unit (RSU) award and a stock option for 30,000 shares at an exercise price of $6.21 per share under the company’s 2021 Stock Option and Incentive Plan. The RSUs, each representing one share of common stock, and the option both vest in full upon the earlier of June 11, 2027 or the next annual meeting of stockholders, contingent on her continued service, reflecting a routine director/insider equity grant rather than an open-market purchase or sale. Following these awards, she reported beneficial ownership of 36,000 shares of common stock (including the RSU award) and an additional option to purchase 30,000 shares. With no market price provided, the dollar value of the awards and her post-transaction holdings cannot be precisely estimated but appear to be a standard-sized annual equity grant for governance and incentive alignment purposes.

Filing Facts

CIK

1501796

Ticker

AURA

Form

4

Source Type

fda

Accession

0001193125-26-271171

Alert Tier

5